Do directors need an annual executive health check?

Evidence checked as of October 2026. Written by The Wellness Team.

Putting health in the diary can be sensible when work repeatedly pushes it aside. That does not mean every director needs the same panel of blood tests and scans every 12 months. An annual conversation, monitoring a known condition and repeating screening tests are different decisions.

Do directors need an executive health check every year?

Not automatically. The right review interval depends on age, existing conditions, family history, previous findings, medicines and the particular screening test. An annual clinical review may be useful for some people, but a yearly date on the calendar does not make every investigation due again. Agree a plan for each part of care rather than renewing a package without discussion.

The useful aim is continuity. If you invest time in an assessment, make sure the results lead to clear actions and a suitable review date. There is no sound basis for promising that an annual executive package will protect a business from absence, guarantee productivity or extend life.

Discuss a preventive health review with The Online GP by The Wellness. The team can confirm the appropriate appointment, availability and fee; additional tests should be agreed around a clinical purpose, not assumed from a job title.

What does the evidence say about annual checks?

The 2019 Cochrane review found that general health checks had little or no effect on total or cancer mortality, and probably little or no effect on cardiovascular mortality. These were studies of general checks, not a verdict against every individual preventive service or treatment of an identified problem. Cochrane review.

A 2021 JAMA review similarly found no general reduction in mortality or cardiovascular events, but reported associations with increased recognition and treatment of chronic disease, better control of some risk factors and greater uptake of preventive services. It did not establish that all adults should receive comprehensive annual examinations and laboratory testing. JAMA review.

The practical conclusion is balanced. Do not dismiss prevention, but do not confuse a repeated bundle with proven benefit. An assessment is most useful when it closes a gap in care, helps a person manage risk or addresses an unresolved concern.

When might a shorter review interval be needed?

Monitoring known high blood pressure, diabetes or another condition is not the same as screening someone who feels well. Starting or changing treatment may require a review earlier than the next annual appointment. An unexplained abnormal result also needs a timescale based on the finding, not the date a screening package renews.

Tell the clinician about changes in symptoms, medicines, family history, smoking, sleep or weight. Some changes alter what needs attention. A normal result last year cannot guarantee that a new concern is harmless now.

Ask for a specific reason for each repeat test. Is it confirming an unexpected finding, checking response to treatment, monitoring safety or reassessing risk? Those questions make the plan more useful than repeating everything to maintain an impressive dashboard.

Can some checks be less frequent than yearly?

Yes. Screening intervals differ by test and risk. The USPSTF suggests annual blood-pressure screening for adults 40 or older and people at increased risk. For low-risk adults 18 to 39 with a previous normal reading, screening every 3 to 5 years may be appropriate. These are US recommendations rather than a personalised UK schedule, but they show why one interval does not fit everyone. Blood-pressure guidance.

NICE advises reviewing estimates of cardiovascular risk on an ongoing basis in people over 40. That does not mean every director needs every blood marker and scan annually. The clinician should explain how overall risk, previous results and current treatment affect the next assessment. NICE NG238.

Keep established screening invitations and routine care in view. An executive assessment should not become a reason to stop attending other appropriate care or to repeat a test unnecessarily just because it is available privately.

Is a baseline useful if it does not prove a diagnosis?

Previous results can provide context. A trend may matter, but measurements vary with circumstances, laboratories and ordinary biological variation. A small change is not automatically deterioration, and a result within a reference range is not a lifetime clearance.

Bring the original report with its date, units and reference interval. If a result is repeated, ask whether the same method is needed and whether the timing or preparation affects interpretation. Where a test needs confirmation, the clinician should explain the next step before a long series of monitoring begins.

Avoid turning health into a competition against an ever-expanding set of numbers. The aim is a decision that helps you, not perfect-looking values or more frequent testing for its own sake.

Should scans be repeated each year for reassurance?

Not simply because a year has passed. A scan may have a defined clinical indication or a specialist follow-up interval. That is different from routine whole-body imaging in someone without a relevant risk or concern.

The American College of Radiology does not consider the evidence sufficient to recommend total-body MRI screening in people without symptoms, risk factors or relevant family history. Uncertain findings can lead to further investigations without established improvement in health. ACR statement.

Before repeating imaging, ask what has changed, what question it answers and how the result will influence care. If a previous scan recommended surveillance, bring the actual report so that the right finding and interval are followed, rather than starting a different generic package.

What makes the year's plan worth acting on?

Leave with a short list of agreed priorities. It should state the action, who is responsible, when it should happen and how completion will be checked. A repeat blood test without someone to review it is not a finished plan. Neither is a referral without a clear route to arrange it.

Work patterns matter to implementation. Tell the clinician about frequent travel, long periods away or a diary that makes attendance difficult. Ask how follow-up will be arranged and whether a remote review is appropriate. Do not assume a particular test, appointment length, turnaround or overseas service is included until it is confirmed.

What should a director book now?

If you feel well and want to review prevention, ask for a clinical assessment that starts with your history and previous care. If you already have an abnormal result or symptoms, explain that at booking so you are directed to the right appointment rather than a generic screen.

New severe chest pain, major breathlessness, collapse or possible stroke symptoms need emergency care, not a routine health check. In the UK, call 999 for an emergency.

For planned care, contact The Online GP by The Wellness. Ask for an individual review plan, a confirmed scope and fee, and a clear arrangement for results and follow-up. The investment is in careful care over time, not automatic annual testing.

Evidence and further reading

General information, not an individual screening recommendation. The right assessment depends on your history, symptoms, risk and preferences. New or urgent symptoms need clinical care, not a routine screening booking.

Previous
Previous

Preparing for executive screening: a director’s appointment checklist

Next
Next

Executive screening for directors: which tests are worth discussing?